WeVote

Bill

Bill

SSB 1241

A bill for an act relating to state government and finances, including by making, modifying, limiting, or reducing appropriations, distributions, or transfers, authorizing expenditure of unappropriated moneys in special funds, providing for properly related matters including crystalline polymorph psilocybin and medical residency and fellowship positions, making corrections, and including effective date and retroactive applicability provisions.

2025-2026 Regular Session

Authorizes adjusting state appropriations/transfers and spending unappropriated funds in special funds, with corrections and related provisions on psilocybin and medical residencies.

Committee report approving bill, renumbered as SF 659.
0
WeVote Research Nonpartisan
Bill Summary · SSB 1241

Summary of SSB 1241 (renumbered SF 659)

Overview

SSB 1241 is a proposed Iowa Senate appropriations bill introduced May 14, 2025, crafted by the Appropriations Committee. The bill would modify state government and finances through adjustments to appropriations and transfers, authorize use of unappropriated funds in special funds, and include related provisions. It also references provisions related to crystalline polymorph psilocybin and medical residency and fellowship positions, along with general corrections and provisions on effective dates and retroactive applicability.

Key Provisions

  • Appropriations authority: The bill allows making, modifying, limiting, or reducing appropriations, distributions, or transfers among state government programs and departments.
  • Unappropriated funds: It would authorize expenditure of unappropriated moneys held in special funds.
  • Related matters: Includes provisions related to crystalline polymorph psilocybin and to medical residency and fellowship positions. The exact mechanisms (funding, regulation, or program development) are not specified in the summary provided, but these topics are explicitly named as parts of the bill.
  • Corrections: Technical or statutory corrections are included.
  • Effective date and retroactivity: The bill contains provisions regarding when its provisions would take effect and whether they apply retroactively to prior fiscal years or actions.

Affected Parties and Areas

  • State government entities: Agencies and departments responsible for state expenditures and special funds.
  • Special funds: Management and use of unappropriated funds within special funds are directly addressed.
  • Education and medical fields: References to medical residency/fellowship positions suggest potential impacts on medical education funding and program support.
  • Policy areas of interest: Administration and regulation appropriations, corrections, economic/financial management, and programs involving psilocybin-related matters.

Fiscal and Procedural Details

  • The bill is an appropriation-focused measure, with potential to redirect or adjust funding and to authorize use of unappropriated funds in special accounts.
  • It includes topics (psilocybin and residency positions) that may entail programmatic funding or regulatory actions, pending further detail.
  • Legislative path to date:
    • Introduced May 14, 2025, and referred to Appropriations.
    • Subcommittee chaired by several members listed in the action notes.
    • Committee report approved the bill and renumbered it as SF 659.

Status and Next Steps

  • Current status: Committee report approving the bill; renumbered as SF 659.
  • Next steps: If advanced, SF 659 would proceed through further readings and votes in the Senate and House, followed by potential gubernatorial action.

Notes

  • The summary reflects the language available in the bill description. Specific fiscal notes, program details, and regulatory mechanisms for the psilocybin-related provisions and medical residency/fellowship positions are not detailed in the provided materials and would be clarified in the full fiscal and legislative analyses.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.